Feds agree to buy 100 M doses of potential Pfizer vaccine
|
July 22, 2020 6:03 AM
The U.S. will pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by Pfizer and its German partner BioNTech.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
